Company Filing History:
Years Active: 2002
Title: Björn Wallmark: Innovator in Therapeutic Preparations
Introduction
Björn Wallmark is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of therapeutic preparations, particularly in the treatment of osteoporosis. His innovative approach has led to the development of a unique inhalation method for delivering essential hormones to patients.
Latest Patents
Björn Wallmark holds a patent for "Therapeutic preparations for inhalation." This invention relates to compositions and methods for pulmonary administration of full-length parathyroid hormone to mammalian hosts for the treatment of osteoporosis. The therapeutic preparation comprises a human full-length parathyroid hormone, or homologues thereof, in the form of a dry powder suitable for inhalation. Notably, at least 50% of this dry powder consists of particles having a diameter of up to 10 microns or agglomerates of such particles.
Career Highlights
Björn Wallmark is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Björn has collaborated with esteemed colleagues such as Kjell Bäckström and Magnus Dahlbäck. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking advancements in therapeutic preparations.
Conclusion
Björn Wallmark's contributions to the field of therapeutic preparations exemplify the impact of innovation in healthcare. His patent for inhalation therapies represents a significant advancement in the treatment of osteoporosis. Through his work at AstraZeneca and collaborations with fellow researchers, he continues to push the boundaries of medical science.